Clinical Trials Browser

Phase 2 × Down Syndrome × Epirubicin × Clear all

NCT03286634 2022-09-28

ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016

Phase 2 Recruiting

LymphoidOther hematologic neoplasm

Down Syndrome, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma